Impact of roxadustat on anemia management in infected patients undergoing long-term dialysis: a retrospective cohort analysis
Overal, roxadustat was more effective than rHuEPO in ameliorating renal anemia in infected dialysis patients.
Authors
- Xiao Tan (ORCID: https://orcid.org/0000-0003-3992-5812)
- Ting Yang (ORCID: https://orcid.org/0000-0001-9560-4576)
- Jing Liu (ORCID: https://orcid.org/0000-0001-8802-0783)
- Lulu Wang (ORCID: https://orcid.org/0000-0003-4366-984X)
- Chunming Jiang (ORCID: https://orcid.org/0000-0002-5934-6570)
- Huimin Qiu
Institutions
- Nanjing University of Chinese Medicine (CN)
- China Pharmaceutical University (CN)
- Changsha Medical University (CN)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-08
- DOI
- https://doi.org/10.3389/fphar.2025.1695376
- Citations
- 1
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.77
Funders
- Nanjing University